GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » cbdMD Inc (AMEX:YCBD) » Definitions » Cyclically Adjusted Price-to-FCF

cbdMD (YCBD) Cyclically Adjusted Price-to-FCF : (As of May. 25, 2025)


View and export this data going back to 2017. Start your Free Trial

What is cbdMD Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


cbdMD Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for cbdMD's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

cbdMD Cyclically Adjusted Price-to-FCF Chart

cbdMD Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

cbdMD Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of cbdMD's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, cbdMD's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


cbdMD's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, cbdMD's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where cbdMD's Cyclically Adjusted Price-to-FCF falls into.


;
;

cbdMD Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

cbdMD's Cyclically Adjusted FCF per Share for the fiscal year that ended in Sep24 is calculated as:

For example, cbdMD's adjusted Free Cash Flow per Share data for the fiscal year that ended in Sep24 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep24 (Change)*Current CPI (Sep24)
=-1.193/133.0289*133.0289
=-1.193

Current CPI (Sep24) = 133.0289.

cbdMD Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201509 0.000 100.392 0.000
201609 -32.870 101.861 -42.928
201709 -14.084 104.136 -17.992
201809 -34.634 106.507 -43.259
201909 -41.879 108.329 -51.428
202009 -11.936 109.815 -14.459
202109 -13.460 115.734 -15.471
202209 -11.789 125.227 -12.524
202309 -2.275 129.860 -2.331
202409 -1.193 133.029 -1.193

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


cbdMD  (AMEX:YCBD) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


cbdMD Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of cbdMD's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


cbdMD Business Description

Industry
Traded in Other Exchanges
Address
2101 Westinghouse Boulevard, Suite A, Charlotte, NC, USA, 28273
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
Executives
Thomas Ronan Kennedy officer: Interim CEO and CFO 8845 RED OAK BLVD, CHARLOTTE NC 28217
Bakari T. Sellers director 4231 VOORHEES ROAD, DENMARK SC 29042
Raines William F Iii director 8314 TOSOMOCK LANE, HUNTERSVILLE NC 28078
Scott G. Stephen director 4249 NORTH WINCHESTER AVE., CHICAGO IL 60613
Sibyl Nichole Swift director 730 HAWTHORNE LANE, APT 441, CHARLOTTE NC 28204
Kevin Macdermott officer: President 9580 CALDWELL RD, MOUNT ULLA NC 28125
Wiesehan John J Iii officer: Chief Revenue Officer 8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Sim Farar director 8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Martin A. Sumichrast director, officer: Chairman of the Board and CEO 11125 COLONIAL COUNTRY LANE, CHARLOTTE NC 28277
Raymond Scott Coffman director 230 S. TRYON ST., #1302, CHARLOTTE NC 28202
Peter J. Ghiloni director 115 DEER ESTATES LANE, PONTE VEDRA BEACH FL 32082
Mark S Elliott officer: CFO & COO C/O LEVEL BRANDS, INC., 4521 SHARON ROAD, SUITE 450, CHARLOTTE NC 28211
Gregory C Morris director 421 CRANBORNE CHASE, FORT MILL SC 29708
Caryn Nicole Dunayer officer: President 8476 CATAWBA DOVE DR., BELMONT NC 28012
Erik Sterling 10 percent owner 5505 KALANIANAOLE HWY, HONOLULU HI 96821

cbdMD Headlines

From GuruFocus

Q1 2023 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q4 2023 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

cbdMD Inc Extraordinary Shareholders Meeting Transcript

By GuruFocus Research 02-15-2024

Q1 2020 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2024 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 05-16-2024

Q3 2020 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2022 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q1 2025 cbdMD Inc Earnings Call Transcript

By GuruFocus News 02-14-2025

Q3 2022 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024